Adult Stem Cell Research: Benefits and Successes
March 28, 2008 | By Jack Yoest
Charmaine presenting a lecture
at Princeton UniversityThere are two major types of stem cell research.
One has the media hype and the hysteria of the Party of Death.
The other has results.
Alert Readers will understand the difference between an adult stem cell and an embryonic stem cell.
Your Business Blogger(R) is often accused of being simple. Dividing the world into Good and Evil.
Adult stem cell research: Good.
Embryonic stem cell research: Evil
The Family Research Council is providing some background,
Adult stem cells are already providing therapeutic benefit to human patients for 73 diseases and conditions.
As seen in,
"Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases" (Journal of the American Medical Association (JAMA), 2/27/2008)
The FRC video clip shows three success stories with Charmaine providing a brief analysis. Click Here for video link. Forgive the extra click to the FRC site.
Amy Daniels, successfully treated with adult stem cells for Systemic Scleroderma
Jill Rosen, successfully treated with adult stem cells for antiphospholipid syndrome (a lupus-like disorder.)
Barry Goudy, successfully treated with adult stem cells for Multiple Sclerosis
Research and cures are now documented without experimentation on humans that results in the destruction of embryos.
The Party of Death
by Ramesh Ponnuru Read more at the jump.
Thank you (foot)notes:
Be sure to visit the Family Research Blog.
Alert Readers will accuse Your Business Blogger(R) of redundancy: The Main Stream Media are all members of The Party of Death.
Charmaine Yoest, Ph.D. is the Vice President for Communications for FRC.
From FRC,
WHAT: Capitol Hill briefing by patients and the doctor who treated them on the therapeutic benefits already being realized with adult stem cell treatments.
With Congress considering funding appropriations for the Dept. of Health and Human Services - which includes The National Institutes of Health - it should give priority and increased resources to funding research that is actually helping patients now. Embryonic stem cells have yet to treat a single human patient and this is unlikely to change in the future. Adult stem cells are already providing therapeutic benefit to human patients for 73 diseases and conditions.
WHO: Dr. Richard Burt, M.D., Northwestern University Feinberg School of Medicine. Dr. Burt's most recent article, "Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases" (Journal of the American Medical Association (JAMA), 2/27/2008), examined hundreds of studies that were conducted between January 1997 and December 2007, and found that therapies using blood- or bone-marrow derived stem cells can successfully and safely treat heart disease and autoimmune disorders. In 2007, Dr. Burt, along with a team of Brazilian doctors, led a groundbreaking study that used adult stem cells to reverse Type 1 (juvenile) diabetes in patients. That study was also reported in JAMA, 4/11/07.
Amy Daniels, successfully treated with adult stem cells for Systemic Scleroderma
Jill Rosen, successfully treated with adult stem cells for antiphospholipid syndrome (a lupus-like disorder.)
Barry Goudy, successfully treated with adult stem cells for Multiple Sclerosis
WHERE: U.S. Capitol Building, HC-9
